Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Metabolic Syndrome and Related Disorders|February 17, 2021
The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type 2 Diabetes MellitusRafael Garcia-Carretero, Luis Vigil-Medina, Oscar Barquero-PerezJournal of Diabetes Research|June 14, 2016
Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes MellitusManuel Varela, Luis Vigil, Carmen Rodriguez, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetesJuan Churruca, Luis Vigil, Esther Luna, et al.Plos One|December 19, 2019
Detrended Fluctuation Analysis in the prediction of type 2 diabetes mellitus in patients at risk: Model optimization and comparison with other metricsAna Colás, Luis Vigil, Borja Vargas, et al.Metabolic Syndrome and Related Disorders|November 2, 2019
Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature SelectionRafael Garcia-Carretero, Luis Vigil-Medina, Oscar Barquero-Perez, et al.Journal of Medical Systems|December 11, 2019
Pulse Wave Velocity and Machine Learning to Predict Cardiovascular Outcomes in Prediabetic and Diabetic PopulationsRafael Garcia-Carretero, Luis Vigil-Medina, Oscar Barquero-Perez, et al.Journal of Diabetes|June 10, 2014
Glucose series complexity at the threshold of diabetesManuel Varela, Carmen Rodriguez, Luis Vigil, et al.Diabetes/Metabolism Research and Reviews|March 9, 2018
New insights from continuous glucose monitoring into the route to diabetesAna Colas, Luis Vigil, Carmen Rodríguez de Castro, et al.Critical Care Medicine|January 14, 2010
Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot studyKrista Lundelin, Luis Vigil, Susana Bua, et al.Journal of the American Society of Hypertension : JASH|April 23, 2010
Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive populationLuis Vigil, Manuel Lopez, Emilia Condés, et al.Pageof 3